XML 14 R2.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Revenues:        
Product revenue $ 39,887 $ 32,978 $ 82,451 $ 66,096
Product revenue - extensible list us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember
Operating expenses:        
Research and development $ 69,878 $ 70,746 $ 138,099 $ 132,777
Selling, general and administrative 41,902 48,029 84,500 95,791
Other operating expenses 355   3,805  
Total expenses 122,535 126,437 247,112 244,756
Operating loss (82,648) (93,459) (164,661) (178,660)
Other income (expense):        
Interest expense (6,739) (3,817) (16,300) (7,407)
Foreign currency gain (loss) 142 (226) (735) (419)
Loss on convertible senior notes conversion     (7,791)  
Loss on extinguishment of debt (3,277)   (3,277)  
Legal settlement loss   (25,000)   (25,000)
Other income 239 1,899 1,081 4,300
Other income (expense), net (9,635) (27,144) (27,022) (28,526)
Loss before income taxes (92,283) (120,603) (191,683) (207,186)
Income tax benefit 36 176 104 336
Net loss (92,247) (120,427) (191,579) (206,850)
Other comprehensive income (loss):        
Foreign currency translation adjustments, net of tax 61 (1) (42) (6)
Net unrealized gain on available-for-sale securities, net of tax (84) 77 (6) 152
Other comprehensive (loss) income: (23) 76 (48) 146
Comprehensive loss $ (92,270) $ (120,351) $ (191,627) $ (206,704)
Loss per basic and diluted common share:        
Basic and diluted net loss per common share $ (1.15) $ (2.27) $ (2.52) $ (3.91)
Basic and diluted weighted average common shares outstanding 80,453 53,028 76,057 52,960
Product        
Operating expenses:        
Cost of sales $ 9,120 $ 6,445 $ 18,216 $ 13,851
Intangible assets amortization        
Operating expenses:        
Cost of sales $ 1,280 $ 1,217 $ 2,492 $ 2,337